Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a prospective, randomized, open label, parallel,6-month study to explore and evaluate the therapeutic effects of Henagliflozin on the cognitive function, olfactory function, and odor-induced brain activation in T2DM patients with mild cognitive impairment (MCI).
Epistemonikos ID: cf0d206bcadcf61eca50648abc77b3984411def6
First added on: May 15, 2024